| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |